To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Cost and committee reports

Official records Congress.gov attaches to H.R. 679.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mrs. HARSHBARGER, as printed in the Congressional Record (Vol. 171, No. 14, January 23, 2025, Page H388):
  Article I; Sec. 8 of the United States Constitution
  Source: Congress.gov, Congressional Record January 23, 2025 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  51 characters

  Congress.gov bill record

  H.R. 679, 119th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/119/hr/679

  Record last updated by Congress.gov

  February 5, 2026

  PORKER copy retrieved

  September 13, 2026

  Stored copy, SHA-256 of the file

  b96d0c93f9af0507a2aa7ac8279f4f259dab8d43e74d0ff68f1d1650e31e7182

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of February 5, 2026). Not every bill gets one.

From the Congress.gov bill record for H.R. 679, last updated February 5, 2026. PORKER’s copy was retrieved September 13, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.